Study Suggests Alzheimer’s Prevention by Anti-Amyloid Drug - According to an open-label study from Washington University in St. Louis, the anti-amyloid drug gantenerumab reduced the risk of developing familial Alzheimer’s disease in a subgroup of participants. But the study has attracted criticism.

[u/Valuable_Pop_7137]

https://www.lifespan.io/news/study-suggests-alzheimers-prevention-by-anti-amyloid-drug/

[u/Little4nt]

We’ve already spent how many hundreds of billions on that approach. Surely another trillion is easier then changing our hypothesis

[u/Responsible_Owl3]

"The results of this very small trial are actually ’null’ – meaning there is no strong evidence of a positive finding. A more accurate interpretation of the findings would be that this drug, like several other drugs before, demonstrated its effectiveness at removing the amyloid protein from the brain. But there was no convincing evidence in this trial that this led to any actual benefit for the participants in terms of the development or worsening of dementia symptoms."

Same as always with amyloid. How many more billions will the pharma companies shovel into this money fire?

[u/SketchySoda → u/Responsible_Owl3]

Honestly, I wish they'd just drop the amyloid stuff already. The bodies likely creating these proteins for a reason and treating/finding the underlying cause makes 1000x more sense. But I guess I shouldn't be surprised with how much fraud centred around amyloids.

[u/Valuable_Pop_7137 → u/Responsible_Owl3]

Yep, its a money pit for sure. We thought it was important to cover this though, even if the results were poor. Its important to talk about failures as well as successes.

[u/Responsible_Owl3 → u/Valuable_Pop_7137]

If so, your title choice could have been better. The title suggests that the drug works, while the evidence shows no strong evidence to prove any effect.